| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.18 | 0.001 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |